| Sample ID |
Sex |
Age |
Diagnosis |
Localization |
Survival |
Models |
| HROG02 |
M |
68 |
GBM (IV) |
R; parietooccipital |
† 7 |
C |
| HROG03 |
M |
50 |
Anaplastic Oligodendroglioma (III) |
R; parietal |
? 9 |
|
| HROG04 |
F |
53 |
Relapsed GBM (IV) |
R; frontal |
† 13 |
C |
| HROG05 |
F |
60 |
Relapsed GBM (IV) |
L; temporal |
† 3 |
C, X |
| HROG06 |
M |
53 |
GBM (IV) |
L; frontal |
† 8 |
C, X |
| HROG07 |
M |
55 |
Relapsed GBM (IV) |
R; temporoparietal |
† 6 |
C |
| HROG08 |
M |
47 |
Relapsed GBM (IV) |
R; frontal |
? 29 |
C |
| HROG09 |
M |
66 |
Anaplastic Astrocytoma (II-III) |
L; temporal |
33 |
|
| HROG10 |
M |
74 |
GBM (IV) |
R; temporal |
† 7 |
C |
| HROG11 |
F |
54 |
GBM (IV) |
L; frontal |
30 |
C |
| HROG12 |
M |
64 |
GBM (IV) |
R; frontoparietal |
† 5 |
C, X |
| HROG13 |
F |
77 |
GBM (IV) |
L; temporal |
† 8 |
C, X* |
| HROG14 |
F |
81 |
Subependymoma (I) |
IV. ventricle |
† 3 |
|
| HROG15 |
M |
56 |
GBM (IV) |
R; parietal |
23 |
C |
| HROG16 |
M |
53 |
GBM (IV) |
R; parietal |
† 26 |
|
| HROG17 |
M |
70 |
Relapsed GBM (IV) |
L; parietooccipital |
† 3 |
C, X |
| HROG18 |
M |
71 |
Relapsed Oligoastrocytoma (II) |
cerebrum |
? 7 |
|
| HROG19 |
M |
69 |
GBM (IV) |
L; temporoparietal |
† 15 |
|
| HROG20 |
M |
34 |
Diffuse Astrocytoma (II) |
L; temporal |
24 |
|
| HROG21 |
M |
44 |
Secondary GBM (IV) |
R; parietal |
21 |
C |
| HROG22 |
M |
66 |
Relapsed GBM (IV) |
L; temporal |
† 4 |
|
| HROG23 |
F |
60 |
Relapsed GBM (IV) |
L; parietal |
20 |
|
| HROG24 |
F |
73 |
GBM (IV) |
L; occipital |
† 10 |
C |
| HROG25 |
F |
77 |
Relapsed GBM (IV) |
L; temporal |
† 3 |
|
| HROG26 |
M |
63 |
Relapsed Astrocytoma (II) |
R; parietal |
† 8 |
|
| HROG27 |
M |
76 |
Meningioma (I) |
cerebrum |
23 |
|
| HROG28 |
F |
76 |
Meningioma (I) |
cerebrum |
? 4 |
|
| HROG29 |
M |
39 |
Diffuse Oligoastrocytoma (II) |
cerebrum |
19 |
|
| HROG30 |
M |
67 |
Meningioma (I) |
frontal |
? 3 |
|
| HROG31 |
F |
59 |
GBM (IV) |
R; occipitotemporal |
21 |
|
| HROG32 |
F |
76 |
GBM (IV) |
R; temporal |
22 |
|
| HROG33 |
F |
46 |
GBM (IV) |
L; occipitotemporal |
† 13 |
C, X |
| HROG34 |
F |
69 |
GBM (IV) |
L; frontal |
† 5 |
|
| HROG35 |
M |
64 |
Relapsed GBM (IV) |
R; occipital |
† 6 |
|
| HROG36 |
F |
80 |
GBM (IV) |
R; parietal |
† 5 |
C |
| HROG37 |
F |
20 |
Pilocytic Astrocytoma (I) |
L; occipital |
? 2 |
|
| HROG38 |
F |
49 |
GBM (IV) |
R; parietooccipital |
19 |
C |
| HROG39 |
F |
59 |
Meningioma (I) |
cerebrum |
18 |
|
| HROG41 |
M |
71 |
Secondary GBM (IV) |
L; frontal |
† 2 |
C |
| HROG42 |
F |
70 |
GBM (IV) |
L; frontal |
16 |
|
| HROG43 |
M |
55 |
Meningioma (I) |
L; frontal |
? 8 |
|
| HROG44 |
M |
69 |
Meningioma (I) |
L; frontal |
? 8 |
|
| HROG45 |
M |
61 |
relapsed Astrocytoma (II) |
L; parietal |
13 |
|
| HROG46 |
F |
69 |
GBM (IV) |
R; parietotemporal |
15 |
|
| HROG47 |
M |
59 |
GBM (IV) |
R; temporal |
† 16 |
|
| HROG48 |
M |
13 |
Pilocytic Astrocytoma (I) |
L; occipital |
13 |
|
| HROG49 |
M |
45 |
Relapsed secondary GBM (IV) |
R; parietooccipital |
? 6 |
|
| HROG50 |
F |
33 |
Diffuse Oligoastrocytoma (II) |
L; frontal |
14 |
|
| HROG52 |
M |
47 |
GBM (IV) |
L; temporobasal |
13 |
X |
| HROG53 |
F |
50 |
Anaplastic Astrocytoma (III) |
cerebrum |
? 4 |
|
| HROG54 |
M |
58 |
GBM (IV) |
R; parietal |
8 |
|
| HROG55 |
F |
74 |
GBM (IV) |
R; parietal |
? 1 |
|
| HROG56 |
F |
76 |
GBM (IV) |
trigonum |
? 5 |
|
| HORG57 |
F |
60 |
Relapsed GBM (IV) |
R; parietal |
8 |
C |
| HROG58 |
F |
57 |
GBM (IV) |
R; frontal |
7 |
C |
| HROG59 |
M |
60 |
Relapsed GBM (IV) |
R; temporal |
† 8 |
C, X |
| HROG60 |
M |
51 |
Relapsed GBM (IV) |
R; temporal |
? 1 |
C |
| HROG61 |
F |
50 |
diffuse Astrocytoma (II) |
L, frontal |
6 |
C |
| HROG62 |
M |
71 |
GBM (IV) |
R; temporoparietal |
4 |
C |
| HROG63 |
M |
48 |
Relapsed GBM (IV) |
L; temporal |
3 |
C |
| HROG64 |
F |
57 |
GBM (IV) |
R; temporal |
1 |
|
The table summarizes patient information on sex (F=female; M=male), age at time point of resection in years, histological diagnosis including WHO grading in parentheses, tumor localization (L=left hemisphere; R=right hemisphere) and survival (†=patient died; bold=patients still alive on January 25th 2013; ?=no information available for > 6 months) in months after resection. Successful cell line establishment is indicated by a C, cell lines characterized in the following are bold and establishment of xenografts by an X. The X* indicates that a xenograft could be established but was lost subsequently |
